These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 5956265)

  • 1. Experimental infection with Candida albicans in modified hosts.
    Hurley R
    J Pathol Bacteriol; 1966 Jul; 92(1):57-67. PubMed ID: 5956265
    [No Abstract]   [Full Text] [Related]  

  • 2. Candida albicans infection in alloxan induced diabetic mice.
    Mukherji AK; Mallik KC
    Indian J Med Res; 1975 Apr; 63(4):539-44. PubMed ID: 1213751
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of experimental diabetes on the development and maintenance of vulvovaginal candidiasis in female rats.
    Carrara MA; Bazotte RB; Donatti L; Svidzinski TI; Consolaro ME; Patussi EV; Batista MR
    Am J Obstet Gynecol; 2009 Jun; 200(6):659.e1-4. PubMed ID: 19286145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of Candida tropicalis infections in mice.
    Louria DB; Busé M; Brayton RG; Finkel G
    Sabouraudia; 1966 Jun; 5(1):14-25. PubMed ID: 5964290
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of route of entry of Candida albicans on the histogenesis of the lesions in experimental candidosis in the mouse.
    Hurley R
    J Pathol Bacteriol; 1966 Oct; 92(2):578-83. PubMed ID: 5964385
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
    Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
    J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Candida albicans (Ch. Robin, 1853), Pseudomonas aeruginosa (Schroeter, 1872), and Morganella morgani (Winslow et al., 1919), proofs of organic decline].
    Assadourian Y; Nicoli RM; Monticelli J; Serafino X
    Mars Med; 1972; 109(6):425-6. PubMed ID: 4628508
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
    Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ
    J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice.
    Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis on the experimental infections of Candida albicans in chickens.
    Tsai SS; Chang CF
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):227-32. PubMed ID: 7140438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphogenesis of candidiasis granuloma].
    Belianin VL; Araviĭskiĭ RA; Elias AV
    Arkh Patol; 1984; 46(12):20-5. PubMed ID: 6395834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and pathological observations with Candida albicans-infected animals.
    Kuttin ES; Müller J; Douchet C; Vogt A
    Sabouraudia; 1983 Sep; 21(3):185-94. PubMed ID: 6356407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typhlitis associated with Candida albicans and Pseudomonas aeruginosa infection in a patient with herbal drug-induced neutropenia.
    Liou JM; Lin JT; Wu MS; Cheng TY; Shun CT; Wang HP
    Ann Hematol; 2005 Oct; 84(10):689-91. PubMed ID: 15902460
    [No Abstract]   [Full Text] [Related]  

  • 14. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene.
    Doyle TC; Nawotka KA; Kawahara CB; Francis KP; Contag PR
    Microb Pathog; 2006 Feb; 40(2):82-90. PubMed ID: 16426810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas-FasL interactions modulate host defense against systemic Candida albicans infection.
    Netea MG; van Der Meer JW; Meis JF; Kullberg BJ
    J Infect Dis; 1999 Nov; 180(5):1648-55. PubMed ID: 10515828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Candida albicans septicemia on the cardiovascular function of rabbits.
    Buluc M; Ataoğlu H; Doğan D; Ergün H; Gürdal H; Erdemli E; Demirel-Yilmaz E
    Int Immunopharmacol; 2005 May; 5(5):893-901. PubMed ID: 15778125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
    Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
    Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice.
    Sundstrom P; Balish E; Allen CM
    J Infect Dis; 2002 Feb; 185(4):521-30. PubMed ID: 11865405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral ketoconazole therapy for experimental candida albicans keratitis in rabbits.
    Ishibashi Y; Matsumoto Y
    Sabouraudia; 1984; 22(4):323-30. PubMed ID: 6095470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.